The antivenom market is a specialized segment of biologics focused on developing, producing, and distributing the****utic serums that neutralize venom from scorpion stings, snake bites, spider envenomation, and other toxic animal exposures. Antivenoms are primarily used in emergency and critical care settings, rural health facilities, and field clinics where exposure to venomous species is common, and rapid intervention is crucial for survival and recovery. This market spans polyvalent and monovalent antivenoms tailored to geographic venom profiles, species-specific product portfolios, and formats suited to varied delivery environments. Recent trends show a growing emphasis on broader-spectrum serums that can address multiple species within a region, as well as improved manufacturing approaches that reduce adverse reactions and improve post-exposure outcomes. These developments are also accompanied by stronger distribution initiatives aimed at making antivenoms more accessible in underserved and high-risk regions.